Abstract
Male stress urinary incontinence (SUI) is most commonly a consequence of prostatic surgery except when symptoms are driven by a neurological concomitant condition. Hence, compared to what urologists know about current clinical practice in female SUI, the diagnostic phase in men is a very particular and important step in the management of the disease, with accurate evaluation of the clinical context, SUI cause, quality of life assessment, and patient complaints [1, 2]. Improvements in urinary leakage after prostatic surgery (RP and TURP) may occur spontaneously or with conservative measures within the first 12 months after surgery. However, management of persistent incontinence is often challenging and may be frustrating for both a patient and his doctor, and as a consequence, it can negatively affect patients’ quality of life and doctor–patient relationship [3]. Urinary incontinence causes problems, such as poor hygiene and loss of self-confidence that directly affect the quality of life of patients. The mechanism for male SUI after prostate surgery appears to be internal sphincter deficiency. The probable mechanism for internal sphincter deficiency after prostate surgery includes rhabdo-sphincter injury during apical dissection, large and deep sutures during vesico-urethral anastomosis, or injury of the neurovascular bundles [3].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lucas MG, Bosch RJ, Burkhard FC, et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2012a;62:1130–42.
Lucas MG, Bosch RJ, Burkhard FC, et al. EAU guidelines on surgical treatment of urinary incontinence. Eur Urol. 2012b;62:1118–29.
Crivellaro S, Morlacco A, Bodo G, Agro’ EF, Gozzi C, Pistolesi D, Del Popolo G, Ficarra V. Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence. Neurourol Urodyn. 2016;35(8):875–81.
Gupta S, Peterson AC. Stress urinary incontinence in the prostate cancer survivor. Curr Opin Urol. 2014;24(4):395–400.
Bauer RM, Gozzi C, Hubner W, et al. Contemporary management of post prostatectomy incontinence. Eur Urol. 2011;59:985–96.
Appell RA. Collagen injection therapy for urinary incontinence. Urol Clin North Am. 1994;21:177–82.
Stenberg A, Larsson E, Lindholm A, Ronneus B, Stenberg A, Läckgren G. Injectable dextranomer-based implant: histopathology, volume changes and DNA analysis. Scand J Urol Nephrol. 1999;33:355–61.
Malizia AA Jr, Reiman HM, Myers RP, et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA. 1984;251:3277–81.
Onur R, Singla A. Comparison of bone-anchored male sling and collagen implant for the treatment of male incontinence. Int J Urol. 2006;13:1207–11.
McGuire EJ. Urethral bulking agents. Nat Clin Pract Urol. 2006;3:234–5.
Poon SA, Silberstein JL, Savage C, et al. Surgical practice patterns for male urinary incontinence: analysis of case logs from certifying American urologists. J Urol. 2012;188:205–10.
Kim PH, Pinheiro LC, Atoria CL, et al. Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis. J Urol. 2013;189:602–8.
Smith D, Appell R, Rackley R, et al. Collagen injection therapy for post-prostatectomy incontinence. J Urol. 1998;160:364–7.
Westney O, Bevan-Thomas R, Palmer J, et al. Transurethral collagen injections for male intrinsic sphincter deficiency: the University of Texas-Houston experience. J Urol. 2005;174:994–7.
Shafik A. Polytetrafluoroethylene injection for the treatment of partial fecal incontinence. Int Surg. 1993;78:159–61.
Altomare DF, La Torre F, Rinaldi M, Binda G, Pescatori M. Carbon-coated microbeads anal injection in outpatient treatment of minor fecal incontinence. Dis Colon Rectum. 2008;5:432–5.
Hussain ZI, Lim M, Stojkovic SG. Systematic review of perianal implants in the treatment of fecal incontinence. Br J Surg. 2011;98:1526–36.
La Torre F, de la Portilla F. Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/dx) for treatment of faecal incontinence. Color Dis. 2013;15:569–74.
Ratto C, Parello A, Dionisi L, et al. Novel bulking agent for faecal incontinence. Br J Surg. 2011;98:1644–52.
Van Kerrebroeck P, ter Meulen F, Farrelly E, et al. Treatment of stress urinary incontinence: recent developments in the role of urethral injection. Urol Res. 2003;30:356–62.
Pycha A, Klinger CH, Haitel A, et al. Implantable microballoons: an attractive alternative in the management of intrinsic sphincter deficiency. Eur Urol. 1998;33:469–75.
Menard S, Porta GD. Incidence, growth and antigenicity of fibrosarcomas induced by Teflon disc in mice. Tumori. 1976;62:565–73.
Witherspoon P, Bryson G, Wright DM, et al. Carcinogenic potential of commonly used hernia repair prostheses in an experimental model. Br J Surg. 2004;91:368–72.
Tjandra J, Tan JJ, Lim F, Murray-Green C. Long-term results of injectable silicone biomaterial for passive fecal incontinence – a randomized trial. Dis Colon Rectum. 2006;49:730–1.
Acknowledgements
We thank, DIEGO COLETTA, NORMA DEPALMA and ILARIA CLEMENTI for contributing to the realization of this chapter.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pennisi, M., Pastore, A.L., La Torre, F. (2020). Bulking Agents for Urinary and Fecal Incontinence. In: Siracusano, S., Dodi, G., Pennisi, M., Gozzi, C., Pastore, A., Cerruto, M. (eds) Complications of Surgery for Male Urinary and Fecal Incontinence. Urodynamics, Neurourology and Pelvic Floor Dysfunctions. Springer, Cham. https://doi.org/10.1007/978-3-319-98264-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-98264-9_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98263-2
Online ISBN: 978-3-319-98264-9
eBook Packages: MedicineMedicine (R0)